Free Account Opening + AMC Free Demat
Loading...

Eris Lifesciences IPO vs GTPL Hathway IPO

Comparision between Eris Lifesciences IPO and GTPL Hathway IPO.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while GTPL Hathway IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the GTPL Hathway IPO is up to ₹484.80 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of GTPL Hathway IPO is ₹170.00 per share.

  Eris Lifesciences IPO GTPL Hathway IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹600.00 per share ₹167.00 per share
Issue Price (Upper) ₹603.00 per share ₹170.00 per share
Issue Price (Final) ₹603.00 per share ₹170.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 24 shares 88 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹240.00 Cr
OFS Issue Size 2,88,75,000 shares 1,44,00,000 shares
OFS Issue Size (Amount)
Issue Size Total 2,88,75,000 shares 2,85,17,650 shares
Issue Size Total (Amount) up to ₹1,741.16 Cr up to ₹484.80 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while GTPL Hathway IPO opens on Jun 21, 2017. The closing date of Eris Lifesciences IPO and GTPL Hathway IPO is Jun 20, 2017, and Jun 23, 2017, respectively.

  Eris Lifesciences IPO GTPL Hathway IPO
Anchor Bid Date
Issue Open Jun 16, 2017 Jun 21, 2017
Issue Close Jun 20, 2017 Jun 23, 2017
Basis Of Allotment (Tentative) Jun 23, 2017 Jun 29, 2017
Initiation of Refunds (Tentative) Jun 27, 2017 Jun 30, 2017
Credit of Share (Tentative) Jun 28, 2017 Jul 03, 2017
Listing date (Tentative) Jun 29, 2017 Jul 04, 2017
Anchor Lockin End date 1 Jul 23, 2017 Jul 29, 2017
Anchor Lockin End date 2 Sep 21, 2017 Sep 27, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to GTPL Hathway IPO P/E ratio of .

  Eris Lifesciences IPO GTPL Hathway IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Dec-16 31-Mar-16 31-Mar-15 31-Mar-14
Total Assets 16,969.16 14,910.26 11,231.49 10,722.93
Total Revenue 6,634.61 7,462.03 6,272.01 5,288.09
Profit After Tax 163.01 45.98 154.85 (84.62)
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in GTPL Hathway IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 58,30,336 shares in GTPL Hathway IPO.

  Eris Lifesciences IPO GTPL Hathway IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,17,500 shares 58,30,336 shares
NII 43,08,750 shares 43,15,689 shares
RII 28,72,500 shares 1,00,69,941 shares
Employee 1,50,000 shares
Others
Total 1,59,48,750 shares 2,02,15,966 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas GTPL Hathway IPO subscribed 1.53x.

  Eris Lifesciences IPO GTPL Hathway IPO
QIB (times) 4.68x 1.48x
NII (times) 0.45x 2.85x
Big NII (times)
Small NII (times)
RII (times) 3.51x 0.99x
Employee (times) 0.86x
Other (times)
Total (times) 3.29x 1.53x

Comments

Add a public comment...